ah 6809 has been researched along with Disease Models, Animal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Bi, Y; Han, M; Jiang, M; Li, S; Xu, J; Xu, X | 1 |
| An, N; Chen, D; Fan, J; Li, J; Liu, C; Luo, J; Su, W; Wang, H; Zhao, J; Zhou, Y | 1 |
| Arosh, JA; Balasubbramanian, D; Banu, SK; Bruner-Tran, KL; Burghardt, RC; Lee, J; Long, CR; Meagher, MW; Osteen, KG; Stanley, JA; Starzinski-Powitz, A | 1 |
| Bagi, Z; Edes, I; Erdei, N; Feher, A; Henrion, D; Kaley, G; Koller, A; Papp, Z; Rutkai, I | 1 |
| Kaur, C; Li, P; Ling, EA; Lu, J; Sivakumar, V; Tan, KL | 1 |
| Anderson, RC; Bartlett, CS; Helfet, DL; Hsu, JF; Lane, JM; Lorich, DG; Rapuano, BE; Tomin, E; Wu, T | 1 |
| Feletou, M; Jensen, BL; Leung, GP; Man, RY; Skott, O; Tang, EH; Vanhoutte, PM | 1 |
8 other study(ies) available for ah 6809 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway.
Topics: Animals; Blood Vessels; Breast Neoplasms; Celecoxib; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Cytokines; Dinoprostone; Disease Models, Animal; Endothelial Cells; Female; Inflammation; Lipopolysaccharides; Lung; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Receptors, Prostaglandin E; Vascular Endothelial Growth Factor A; Xanthones | 2015 |
Oxytocin evokes a pulsatile PGE2 release from ileum mucosa and is required for repair of intestinal epithelium after injury.
Topics: Animals; Antineoplastic Agents; Calcium; Cyclooxygenase 2; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Evoked Potentials; Fluorouracil; Ileum; Immunohistochemistry; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Ions; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Neoplasms; Oxytocin; Rats; Rats, Wistar; Receptors, Oxytocin; Wound Healing; Xanthones | 2015 |
Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.
Topics: Animals; Apoptosis; Biphenyl Compounds; Caspase 3; Cell Line; Cell Movement; Cell Survival; Disease Models, Animal; Endometriosis; Endometrium; Estrogens; Female; Humans; Inflammation; Mice; Neovascularization, Pathologic; Pelvic Pain; Poly(ADP-ribose) Polymerases; Progesterone; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Steroids; Xanthones | 2015 |
Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Diabetes Mellitus; Dinoprostone; Disease Models, Animal; Hypertension; Male; Mice; Mice, Mutant Strains; Muscle, Skeletal; Prostaglandin Antagonists; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Vascular Resistance; Vasoconstrictor Agents; Xanthones | 2009 |
Expression of cyclooxygenase-1/-2, microsomal prostaglandin-E synthase-1 and E-prostanoid receptor 2 and regulation of inflammatory mediators by PGE(2) in the amoeboid microglia in hypoxic postnatal rats and murine BV-2 cells.
Topics: Animals; Animals, Newborn; CD11b Antigen; Cell Line; Cell Movement; Cell Survival; Cyclic AMP; Cytokines; Dinoprostone; Disease Models, Animal; Encephalitis; Hypoxia, Brain; Intramolecular Oxidoreductases; Mice; Microglia; Microsomes; Nitric Oxide Synthase Type II; Prostaglandin Antagonists; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; RNA, Messenger; Signal Transduction; Xanthones | 2009 |
Early changes in prostaglandins precede bone formation in a rabbit model of heterotopic ossification.
Topics: Animals; Cyclic AMP; Disease Models, Animal; Femur; Follow-Up Studies; Hindlimb; Immobilization; Muscle, Skeletal; Ossification, Heterotopic; Osteogenesis; Prostaglandin Antagonists; Prostaglandins; Rabbits; Radiography; Thionucleotides; Time Factors; Xanthones | 2006 |
The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydrazines; Hypertension; Immunohistochemistry; Naphthalenes; Phenylephrine; Potassium Chloride; Propionates; Prostaglandin Antagonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Thromboxane; Sulfonamides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Xanthones | 2008 |